Specificity of 6-hydroxydopamine-induced destruction of mesolimbic or nigrostriatal dopamine-containing terminals.
D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects*; D004298:Dopamine / Q000032:analysis; D005968:Glutamate Decarboxylase / Q000378:metabolism; D006892:Hydroxydopamines / Q000494:pharmacology*; D008032:Limbic System / Q000187:drug effects*; D008297:Male; D009411:Nerve Endings / Q000187:drug effects* / Q000201:enzymology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects*
D006892:Hydroxydopamines; D010727:Phosphoric Diester Hydrolases; D005968:Glutamate Decarboxylase; D004298:Dopamine